Clinical Treatment and Prognostic Analysis on Colorectal Carcinoma with Neuroendocrine Cell Differentiation

ZHANG Ting-ting,SHI Wei-wei,SU Dan
DOI: https://doi.org/10.16766/j.cnki.issn.1674-4152.2012.08.075
2012-01-01
Abstract:Objective To investigate the clinicopathological features,treatment and prognosis of colorectal carcinoma with neuroendocrine cell differentiation.Methods A total of 16 patients from 2005 to 2010 were treated for colorectal carcinoma with neuroendocrine cell differentiation in the PLA Hospital.The clinical data were retrospectively analyzed.Results Sixteen patients had colorectal carcinoma with neuroendocrine cell differentiation in the rectum(n=5),ascending colon(n=4),ileocecal junction(n=3),sigmoid colon(n=2),transverse colon(n=1) or descending colon(n=1).Clinical manifestations were mostly non-specific.Diagnosis was based on pathological and immunohistochemical examination.All the patients underwent surgery including radical resection or partial resection,of whom with liver metastasis underwent transcatheter hepatic arterial chemoembolization(TACE).The remaining one patient with liver metastasis and lung metastasis only received palliative surgery.All the patients received chemotherapy.The survival rate was 73%.Conclusion The colorectal carcinoma with neuroendocrine cell differentiation usually develops in the rectal but can occur in any locations of the colorectal.The immunohistochemical examination is important to the diagnosis.Radical resection and suitable chemotherapy is the main treatment.
What problem does this paper attempt to address?